

In the Top 50% of 1808 Similar Sized Companies on Comparably
In the Bottom 35% of 270 Nearby Companies in Boston
6th place versus 5 competitors rated on Comparably
Mr. Michel Vounatsos has been the Chief Executive Officer of Biogen Inc. since January 6, 2017. Mr. Vounatsos served as the Chief Commercial Officer and Executive Vice President of Biogen Inc. since April 18, 2016 until December 2016. He is a sophisticated global business leader who has a track record of commercial success and creativity. He joined Biogen after a 20 year career at Merck, where he various positions including served as president, Primary Care Business Line and Merck Customer Centricity. Prior to this role, he held leadership positions at Merck across Europe and in China. He has been Director of Biogen Inc. since January 6, 2017. Mr. Vounatsos attended the Universite Victor Segalen, Bordeaux II, in France, receiving his C.S.C.T. certificate in Medicine. He received his M.B.A. from the HEC School of Management in Paris.
The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Biogen.
Based on 147 ratings, Michel Vounatsos ranks right below Emergent Biosolutions' CEO, Joseph C. Papa.
Biogen's CEO is highly regarded by the HR department, African American/Black employees, and employees with 6 to 10 Years experience. However, the Customer Support department, employees with 3 to 6 Years experience, and Asian or Pacific Islander employees have a less favorable view of the CEO and believe there is room for improvement. Overall, the CEO score has remained stable over the last 90 days.
Biogen ranks in the Top 50% of other companies on Comparably with 5,001-10,000 Employees for CEO Rating Score.
Biogen ranks in the Bottom 35% of other companies in Boston for CEO Rating Score.
